NCNA
|
NuCana plc
|
US
|
NASDAQ
|
NEO
|
NeoGenomics, Inc.
|
US
|
NASDAQ
|
NEXI
|
NexImmune, Inc.
|
US
|
NASDAQ
|
NKTX
|
Nkarta, Inc.
|
US
|
NASDAQ
|
NRIX
|
Nurix Therapeutics, Inc.
|
US
|
NASDAQ
|
NSTG
|
NanoString Technologies, Inc.
|
US
|
NASDAQ
|
NUVB
|
Nuvation Bio Inc.
|
US
|
NYSE
|
NUVL
|
Nuvalent, Inc.
|
US
|
NASDAQ
|
NVCR
|
NovoCure Limited
|
US
|
NASDAQ
|
NVCT
|
Nuvectis Pharma, Inc.
|
US
|
NASDAQ
|
NVTA
|
Invitae Corporation
|
US
|
NYSE
|
NXTC
|
NextCure, Inc.
|
US
|
NASDAQ
|
OCX
|
OncoCyte Corporation
|
US
|
NASDAQ
|
ONCR
|
Oncorus, Inc.
|
US
|
NASDAQ
|
ONCT
|
Oncternal Therapeutics, Inc.
|
US
|
NASDAQ
|
ONCY
|
Oncolytics Biotech Inc.
|
US
|
NASDAQ
|
ONTX
|
Onconova Therapeutics, Inc.
|
US
|
NASDAQ
|
OPK
|
OPKO Health Inc.
|
US
|
NASDAQ
|
ORIC
|
Oric Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
PBLA
|
Panbela Therapeutics, Inc.
|
US
|
NASDAQ
|